Jazz Pharmaceuticals plc — Director's Dealing 2022

Jan 14, 2022

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2021-12-31

Reporting Person: Carr Patricia (SVP, Chief Accounting Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-03	Ordinary Shares	S	147	$136.62	Disposed	5888	Direct
2021-09-03	Ordinary Shares	S	143	$136.48	Disposed	5745	Direct
2021-11-30	Ordinary Shares	J	63	$101.4645	Acquired	5808	Direct

Footnotes

F1: Includes 147 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 28, 2021. This acquisition is exempt pursuant to Rule 16b-3(c).

F2: Shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2021. This transaction is exempt pursuant to Rule 16b-3(c).